SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009154
Filing Date
2020-08-04
Accepted
2020-08-04 16:27:50
Documents
74
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20200630x10q.htm   iXBRL 10-Q 2430501
2 EX-1.1 rigl-20200630xex1d1.htm EX-1.1 268091
3 EX-5.1 rigl-20200630xex5d1.htm EX-5.1 9636
4 EX-10.1 rigl-20200630xex10d1.htm EX-10.1 196187
5 EX-31.1 rigl-20200630xex31d1.htm EX-31.1 16297
6 EX-31.2 rigl-20200630xex31d2.htm EX-31.2 16948
7 EX-32.1 rigl-20200630xex32d1.htm EX-32.1 8777
8 GRAPHIC rigl-20200630xex5d1001.jpg GRAPHIC 4113
9 GRAPHIC rigl-20200630x10q004.jpg GRAPHIC 74237
  Complete submission text file 0001558370-20-009154.txt   9103641

Data Files

Seq Description Document Type Size
10 EX-101.SCH rigl-20200630.xsd EX-101.SCH 51428
11 EX-101.CAL rigl-20200630_cal.xml EX-101.CAL 50303
12 EX-101.DEF rigl-20200630_def.xml EX-101.DEF 173567
13 EX-101.LAB rigl-20200630_lab.xml EX-101.LAB 469725
14 EX-101.PRE rigl-20200630_pre.xml EX-101.PRE 325007
15 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20200630x10q_htm.xml XML 1640340
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 201073696
SIC: 2834 Pharmaceutical Preparations